Literature DB >> 10368122

Char syndrome, an inherited disorder with patent ductus arteriosus, maps to chromosome 6p12-p21.

M Satoda1, M E Pierpont, G A Diaz, R A Bornemeier, B D Gelb.   

Abstract

BACKGROUND: Patent ductus arteriosus (PDA) is a relatively common form of congenital heart disease. Although polygenic inheritance has been implicated, no specific gene defects causing PDA have been identified to date. Thus, a positional cloning strategy was undertaken to determine the gene responsible for the Char syndrome, an autosomal dominant disorder characterized by PDA, facial dysmorphism, and hand anomalies. METHODS AND
RESULTS: A genome scan was performed with 46 members of 2 unrelated families in which the disease was fully penetrant but the phenotype differed. Significant linkage was achieved with several polymorphic DNA markers mapping to chromosome 6p12-p21 (maximal 2-point LOD score of 8.39 with D6S1638 at theta=0.00). Haplotype analysis identified recombinant events that defined the Char syndrome locus with high probability to a 3. 1-cM region between D6S459/D6S1632/D6S1541 and D6S1024.
CONCLUSIONS: A familial syndrome in which PDA is a common feature was mapped to a narrow region of chromosome 6p12-p21. Additional analysis with other families and polymorphic markers as well as evaluation of potential candidate genes should lead to the identification of the Char syndrome gene, which will provide insights into cardiogenesis as well as limb and craniofacial development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10368122     DOI: 10.1161/01.cir.99.23.3036

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

1.  Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation.

Authors:  F Zhao; C G Weismann; M Satoda; M E Pierpont; E Sweeney; E M Thompson; B D Gelb
Journal:  Am J Hum Genet       Date:  2001-08-14       Impact factor: 11.025

2.  Genetic variants associated with patent ductus arteriosus in extremely preterm infants.

Authors:  John M Dagle; Kelli K Ryckman; Cassandra N Spracklen; Allison M Momany; C Michael Cotten; Joshua Levy; Grier P Page; Edward F Bell; Waldemar A Carlo; Seetha Shankaran; Ronald N Goldberg; Richard A Ehrenkranz; Jon E Tyson; Barbara J Stoll; Jeffrey C Murray
Journal:  J Perinatol       Date:  2018-12-05       Impact factor: 2.521

3.  Familial nonsyndromic patent ductus arteriosus caused by mutations in TFAP2B.

Authors:  Yi-Wei Chen; Wu Zhao; Zhi-Fang Zhang; Qihua Fu; Jie Shen; Zhen Zhang; Wei Ji; Jian Wang; Fen Li
Journal:  Pediatr Cardiol       Date:  2011-06-04       Impact factor: 1.655

4.  Syndromic patent ductus arteriosus: evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorder.

Authors:  Arya Mani; Jayaram Radhakrishnan; Anita Farhi; Khary S Carew; Carole A Warnes; Carol Nelson-Williams; Ronald W Day; Barbara Pober; Matthew W State; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

5.  Determination of genetic predisposition to patent ductus arteriosus in preterm infants.

Authors:  John M Dagle; Nathan T Lepp; Margaret E Cooper; Kendra L Schaa; Keegan J P Kelsey; Kristin L Orr; Diana Caprau; Cara R Zimmerman; Katherine M Steffen; Karen J Johnson; Mary L Marazita; Jeffrey C Murray
Journal:  Pediatrics       Date:  2009-04       Impact factor: 7.124

6.  Current Perspectives on Pathobiology of the Ductus Arteriosus.

Authors:  Jason Z Stoller; Sara B Demauro; John M Dagle; Jeff Reese
Journal:  J Clin Exp Cardiolog       Date:  2012-06-15

7.  A heart-hand syndrome gene: Tfap2b plays a critical role in the development and remodeling of mouse ductus arteriosus and limb patterning.

Authors:  Feng Zhao; Anja-Katrin Bosserhoff; Reinhard Buettner; Markus Moser
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

8.  Genetic Basis of Human Congenital Heart Disease.

Authors:  Shannon N Nees; Wendy K Chung
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-09-01       Impact factor: 9.708

Review 9.  Patent arterial duct.

Authors:  Jonathan T Forsey; Ola A Elmasry; Robin P Martin
Journal:  Orphanet J Rare Dis       Date:  2009-07-10       Impact factor: 4.123

Review 10.  Focused Strategies for Defining the Genetic Architecture of Congenital Heart Defects.

Authors:  Lisa J Martin; D Woodrow Benson
Journal:  Genes (Basel)       Date:  2021-05-28       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.